Mitral Valve Prolapse

Clinical Trial Finder

Many patients with mitral valve prolapse are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

POTS Adrenergic Ab (CIHR Aims #1&2)

Condition:   Postural Tachycardia Syndrome
Interventions:   Drug: Phenylephrine;   Drug: Isoproterenol
Sponsor:   University of Calgary
Recruiting - verified February 2016

Safety and Early Feasibility Study of the Harpoon Medical Device

Conditions:   Mitral Valve Regurgitation;   Mitral Valve Prolapse;   Mitral Valve Insufficiency
Intervention:   Device: Mitral Valve Repair
Sponsor:   Harpoon Medical
Recruiting - verified February 2016

Essential Hypotension and Adaptability Registry

Conditions:   Blood Pressure;   Depression;   Panic Attack;   Fibromyalgia;   POTS;   Inappropriate Sinus Tachycardia;   Coronary Heart Disease;   Acute Coronary Syndrome (ACS);   Acute Myocardial Infarction (AMI);   Cerebrovascular Disease (CVD);   Transient Ischemic Attack (TIA);   Atrial Fibrillation;   Diabetes Mellitus;   Cancer;   Systolic Heart Failure;   Diastolic Heart Failure;   Chronic Fatigue Syndrome;   Syncope;   Vasovagal Syncope
Intervention:  
Sponsor:   CES University
Recruiting - verified February 2016

High Sodium Diet and External Abdominal Compression in POTS

Condition:   Postural Orthostatic Tachycardia Syndrome
Intervention:   Device: External automated abdominal binder
Sponsor:   Vanderbilt University
Recruiting - verified January 2016

Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome

Condition:   Marfan Syndrome
Intervention:   Other: Blood draw
Sponsors:   Ann & Robert H Lurie Children's Hospital of Chicago;   Johns Hopkins University
Withdrawn - verified February 2016